Eli Lilly (LLY) ended the recent trading session at $912.76, demonstrating a -1.82% swing from the preceding day's closing price. The stock's performance was behind the S&P 500's daily loss of 1.78%.

Late-breaking results from Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY) found adolescent patients (ages 12 to under 18) with severe alopecia areata (AA) treated with once-daily ...

March 8 (Saturday) St. Bonaventure @ Vols BSB, 6 p.m. SECN+ March 9 (Sunday) UTC Women vs. top-seeded UNCG, Southern Conference Tournament title game, Noon on ESPNU St. Bonaventure ... more ...

Eli Lilly has unveiled a $2.5 billion deal to acquire rights to a cancer therapy being developed by Scorpion Therapeutics in a third major transaction announced on the first day of the JP Morgan ...

Eli Lilly has raised its revenue guidance for 2024 by $3 billion, after reporting strong growth for tirzepatide in diabetes and obesity, fuelled by the end of supply constraints for starting doses.

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

Sophie Turner, Kate Moss, Nara Smith - the most stylish A-list attendees spotted in the 'City of Light' for the autumn-winter shows ...

After hours: 7 March at 19:59:57 GMT-5 Loading Chart for LLY ...